2018, Number 4
<< Back Next >>
Aten Fam 2018; 25 (4)
Infectious Viral Mumps: Review, Epidemiological Panorama and Challenges
Díaz CFG
Language: Spanish
References: 27
Page: 162-168
PDF size: 369.14 Kb.
ABSTRACT
The mumps virus (MuV) is the etiologic
agent of benign viral mumps, it is transmitted
by respiratory drops, incubates
from 12 to 25 days, the symptoms are
presented 16 to 18 days after exposure
and the main organ affected are the parotids
glands in which local and intense
inflammation occurs. The most severe
complication is orchitis, which is presented
in post-pubertal men. Serology is
the simplest method for confirming MuV
infection and enzyme immunoassay is the
most commonly used test. This disease has
no specific treatment; specific prevention
is the vaccine, which is composed of live
attenuated viruses of the Jeryl Lynn strain
and has an efficacy of 88%. Since 2012,
increases in the number of mumps cases,
incidence, number of bouts, and the proportion
of cases associated with outbreaks
have been reported, so it is described, in
broad terms, infectious viral mumps, its
situation in the world, in Mexico, and
vaccination challenges.
REFERENCES
Centers for Disease Control and Prevention. Mumps. In Hamborsky J KAWSe, editor. Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington D.C.: Public Health Foundation; 2015; 247-260.
Murray, Patrick R, Ken S. Rosenthal, and Michael A. Pfaller. Paramixovirus. In Murray prksr. Medical Microbiology. Philadelphia: Elsevier/Saunders; 2013; 604-606.
who. Mumps: who position paper. Weekly epidemiological record. 2007;16(7):33-34.
Cui A, Zhu Z, Hu Y, et al. Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015. PLoS ONE. 2017. Doi: https://doi.org/10.1371/journal. pone.0169561
Jin L, Örvell C, Myers R, Rota PA, Nakayama T, Forcic D, Hiebert J, Brown KE. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Rev Med Virol. 2015;25(2): 85-101.
Magurano F, Baggieri M, Marchi A, Bucci P, Rezza G, Nicoletti L. Mumps clinical diagnostic uncertainty. Eur J Public Health. 2018;28(1):119-123.
Ramanathan R, Voigt EA, Kennedy RB, Poland GA. Knowledge gaps persist and hinder progress in eliminating mumps. Vaccine. 2018;36(26):3721- 3726. Doi: 10.1016/j.vaccine.2018.05.067.
Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;15(971(9616)):932-44.
Taparelli F, Squadrini F, De Rienzo B, Lami G, Fornaciari A. Isolation of mumps virus from vaginal secretions in association with oophoritis. J Infect. 1988 Nov; 17(3):255-8.
Vaidya SR, Chowdhury DT, Jadhav SM, Hamde VS. Complete genome sequence of mumps viruses isolated from patients with parotitis, pancreatitis and encephalitis in India. Infect Genet Evol. 2016;39:272-78.
cdc. Brief report: update: mumps activity. United States, January 1-October 7, 2006. MMWR Morb Mortal Wkly Rep. 2006;(55):1152-53.
Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580-89.
Secretaría de Salud. Dirección General de Epidemiología. Lineamientos para la vigilancia epidemiológica de la enfermedad febril exantemática por laboratorio. [Internet] 2015 [Citado 2018 Jun 12]. Disponible en: https://www. gob.mx/cms/uploads/attachment/file/159097/ Lineamientos_para_la_vigilancia_epidemiologica_ de_enfermedad_febril_exantematica.pdf
Yang Q, Yang Z, Ding H, et al. The relationship between meteorological factors and mumps incidence in Guangzhou, China, 2005-2012: A distributed lag nonlinear time-series analysis. Human Vaccines & Immunotherapeutics. 2014;10(8):2421-32.
Latner DR, Hickman CJ (2015) Remembering Mumps. PLoS Pathog 11(5): e1004791. https:// doi.org/10.1371/journal.ppat.1004791
Organización Mundial de la Salud. Incidencia de Enfermedades Prevenibles por Vacunación. [Internet] 2018 [Citado 2018 Julio 2] Disponible en: http://apps.who.int/immunization_monitoring/ globalsummary/timeseries/tsincidencemumps.html
Marin M. Update on mumps epidemiology, United States. Atlanta, GA: CDC, Presentation at the Advisory Committee on Immunization Practices meeting; 2017.
Diario Oficial de la Federación. Secretaría de Salud. Norma Oficial Mexicana nom-017-SSA2-2012, Para la vigilancia epidemiológica. [Internet] 2013 [Citado 2018 Jun 26] Disponible en: http://dof. gob.mx/nota_detalle.php?codigo=5288225&fec ha=19/02/2013.
Secretaría de Salud. Dirección General de Epidemiología. Sistema Nacional de Vigilancia Epidemiológica. Información Epidemiológica. [Internet] 2008-2018 [Citado 2018 Jun 28] Disponible en: https://www.gob.mx/salud/accionesy- programas/informacion-epidemiologica
Bockelman C, Frawley TC, Long B, Koyfman A. Mumps: An Emergency Medicine-Focused Update. J Emerg Med. 2018;54(2):207-214.
Secretaría de Salud - CENSIA. Lineamientos Generales del Programa de Vacunación Universal y Semanas Nacionales de Salud 2018. [Internet] 2017 [Citado 2018 Jul 19] Disponible en: https://www. gob.mx/cms/uploads/attachment/file/294272/ Lineamientos_PVU_y_SNS_2018_corregidos.pdf
Marin M, Marlow M, Moore KL, Patel M. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. mmwr Morb Mortal Wkly Rep. 2018;67(1):33-38.
Méndez-Herrera A, Arias-Toledo E, Sánchez-Alemán M, Olamendi-Portugal ML, Ruiz-Gómez J, Díaz-Ortega JL. Antibody prevalence to mumps in children and adolescents at two years of the introduction of the MMR vaccine. Salud Publica Mex. 2018;Jan-Feb;60(1):p.71-76.
May M, Rieder CA, Rowe RJ. Emergent lineages of mumps virus suggest the need for a polyvalent vaccine. Int J Infect Dis. 2018;Jan;66:p.1-4.
Ma C, Liu Y, Tang J, Jia H, Qin W, Su Y, Wang H, Hao L. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China. Hum Vaccin Immunother. 2018 Jun;14(6):p.1392-97.
Principi N, Esposito S. Mumps outbreaks: A problem in need of solutions. J Infect. 2018 Jun;76(6):503-6.
Plotkin SA. Mumps: A Pain in the Neck. J Pediatric Infect Dis Soc. 2018 May; 7(2):91-92.